Literature DB >> 13396633

Fatal disseminated moniliasis during prolonged antibiotic therapy.

M G CHAPMAN.   

Abstract

Keywords:  ANTIBIOTICS/injurious effects; MONILIASIS/in infant and child

Mesh:

Substances:

Year:  1957        PMID: 13396633      PMCID: PMC1511853     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


× No keyword cloud information.
  17 in total

1.  Systemic moniliasis treated with mycostatin; case report.

Authors:  R C ROBINSON
Journal:  J Invest Dermatol       Date:  1955-04       Impact factor: 8.551

2.  Treatment of genitourinary moniliasis with orally administered nystatin.

Authors:  A B SAREWITZ
Journal:  Ann Intern Med       Date:  1955-06       Impact factor: 25.391

3.  Disseminated candidiasis.

Authors:  A SCHABERG; J A HILDES; J C WILT
Journal:  AMA Arch Intern Med       Date:  1955-01

4.  Pathogenesis of Candida albicans infection following antibiotic therapy. I. The effect of antibiotics on the growth of Candida albicans.

Authors:  M HUPPERT; D A MACPHERSON; J CAZIN
Journal:  J Bacteriol       Date:  1953-02       Impact factor: 3.490

5.  Treatment of broncho-pulmonary moniliasis by dye inhalation.

Authors:  I KASS; K T SASANO; W S KLEIN
Journal:  Dis Chest       Date:  1952-02

6.  Monilial infections complicating the therapeutic use of antibiotics.

Authors:  J W WOODS; I H MANNING; C N PATTERSON
Journal:  J Am Med Assoc       Date:  1951-01-27

7.  Moniliasis pneumonia following aureomycin therapy.

Authors:  F W WOLFF
Journal:  Lancet       Date:  1952-06-21       Impact factor: 79.321

8.  Are Fungus infections increasing as a result of antibiotic therapy?

Authors:  A M KLIGMAN
Journal:  J Am Med Assoc       Date:  1952-07-12

9.  Effect of fungicidin (nystatin) in mice injected with lethal mixtures of aureomycin and Candida albicans.

Authors:  R BROWN; E L HAZEN; A MASON
Journal:  Science       Date:  1953-05-29       Impact factor: 47.728

10.  A new antifungal antibiotic, mycostatin (nystatin), for the treatment of moniliasis: a preliminary report.

Authors:  M B SLOANE
Journal:  J Invest Dermatol       Date:  1955-06       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.